Ram Kumar Selvaraju

forskare vid Institutionen för läkemedelskemi, Plattformen för preklinisk PET-MRI

E-post:
ramkumar.selvaraju[AT-tecken]ilk.uu.se
Besöksadress:
Biomedicinskt Centrum BMC, Husargatan 3
Postadress:
Dag Hammarskjöldsv 14C, 3 tr
751 83 Uppsala

Kort presentation

Detta stycke finns inte på svenska, därför visas den engelska versionen.

I am a biotechnologist and my interest incline toward molecular imaging,specializing in use of positron emission tomography (PET) as a tool for preclinical evaluation of novel tracers in drug development.


Nyckelord: diabetes beta cell imaging molecular imaging pet spect ct preclinical neuroendocrine cancer

Detta stycke finns inte på svenska, därför visas den engelska versionen.

2017- Researcher, Uppsala University (UU), Sweden

2016-2017 Post doctoral researcher, UU, Sweden.

2011-2015 Ph. D. in Pharmacy, UU, Sweden.
Thesis Title: [68Ga]Exendin-4: Bench-to-Bedside.

2009-2011 M. Sc. in Medical Nuclide Techniques, UU, Sweden.

2005-2009 B.Tech in Biotechnology, VIT University, India.

----------------------------------------------------------------------------------------------

Research routines are preclinical oriented with use of

* Short lived positron emitting radionuclide such as [11C] ,[18F] & [68Ga]
* Long lived SPECT radionuclides such as [99mTc], [111In] & [177Lu]
* Human islets and cancer cell lines of pancreatic origin.
* Autoradiography
* Small animal models
* In vivo imaging in small animals with PET, SPECT, CT and MR
* Image analysis using software’s such as PMOD, AMIRA, AMIDE and Image J.

Kontakta katalogansvarig vid den aktuella organisationen (institution eller motsv.) för att rätta ev. felaktigheter.

Ram Kumar Selvaraju
Senast uppdaterad: 2021-03-09